
Biotech cannabinoid company, Panacea Life Sciences, Inc. (OTCQB:PLSH), expanded its skincare line with innovative CBD and CBG formulations to help combat skin issues like acne, wrinkles, and even more severe conditions such as eczema and psoriasis.
According to the company, these products, specifically the Skin Clearing Gel for acne and the Derma Soothe CBD+CBG oil for more severe conditions, capitalize on the growing CBD skincare market which is estimated to be worth $1295.7 Million by 2026 and is foreseen to garner a CAGR of about 33% from 2021 to 2026.